Ampelokipoi 210-6983 222 | 213-0312 000
Gizi 216-070 0000

Online Digital Exam Portfolio

Display – print the test results of the desired referrer – command

Give, with absolute security, access to the third parties you wish


What is this?

Thrombophilia is characterized by the condition in which hematological disorders give the tendency to form clots in any random part of the body.

Check Up Medicus | Autoimmune thrombophilia. Biochemical analyzes in test packages with a price from 83 euros.


The formation of clots can be caused individually or when there is a combination of:

  1. autoimmune diseases and acquired – environmental factors
  2. genetically transmitted factors

Signs of thrombophilia may be considered:

  1. personal history of thrombophlebitis, ischemic episodes, recurrent pregnancies
  2. family history of strokes, myocardial infarctions, thromboembolisms
Etiology thrombophilia tests are aimed at people who:
  1. have a personal or family history of blood clots
  2. fill the criteria of high cardiovascular risk (smoking, hypertension, dyslipidemia, obesity, etc.)
  3. will take contraceptives or have high-risk pregnancies – recurrent pregnancies
Successful diagnosis and preventive treatment are absolutely necessary for the overall safety of the organism.


Firstly, the biochemical control of thrombophilia is done with analyzes that directly detect disorders in coagulation, by measuring the corresponding coagulation factors.

Further analysis is done by:

  1. immune control and the detection of possible autoimmune factors of the immune system that cause thrombophilia
  2. genetic testing and the detection of inherited genes that cause thrombophilia

A Biochemical Check

Basic coagulation factors and the basic marker of intravascular inflammation associated with thrombophilia are measured.

Platelets (Plt): they are the cells of the natural mechanism of clot formation and hemostasis. Their increased values, which we often observe in inflammatory processes, are an indication of an increased risk of clot formation.

Prothrombin time (PT – INR): performed as an initial test of blood clotting time in laboratory conditions. If low values are found, that indicate hypercoagulability (INR ​​< 1.00), then we recommend a repeat on another day and possibly additional tests.

Partial thromboplastin time (PTT): performed as a complementary to PT-INR clotting time measurement in laboratory conditions. Prolonged APTT times are associated with autoimmune diseases that cause thrombophilia.

Fibrinogen (Fibr): constitutes the 'raw material' for the normal formation of clots and hemostasis. Elevated levels are associated with increased chances of clot formation. Fibrinogen is increased from inflammatory conditions (and smoking) that cause cardiovascular disease.

D-Dimers: are the degradation products of fibrinogen and clots that have probably been formed recently. Elevated levels generally indicate a present thrombotic state of the body and an increased risk of thromboembolism.

Homocysteine (Hcy): is a marker of intravascular inflammation. High homocysteine values can be caused by vitamin deficiency, smoking, obesity, or genetic factors. It is itself an irritant factor of the vessels and its values are proportional to the possibility of clot formation.

B Immunological control

If the picture we have from the first level is not satisfactory (e.g. high APTT), then we look for possible sources of thrombophilia from disorders of the immune system and autoimmune diseases. Basic laboratory tests are:

Proteins S and C (PrS and PrC): reflect the state of the immune system. Their low values indicate possible long-term exhaustion of the immune system (possible long-term autoimmune diseases) and the increased possibility of blood clots.

Lupus anticoagulant (PTT-la): detects the presence of autoimmune lupus, which is an independent risk factor for thrombotic incidents.

Anticardiolipins (αCL IgG, αCL IgM, αCL IgA): are autoantibodies responsible for antiphospholipid syndrome. The specific autoantibodies affect the blood vessels – they activate platelets and give an increased possibility of clot formation.

C Genetic laboratoey testing for thrombophilia

Genetic testing is widely considered as a basic check-up for cardiovascular risk. The analysis is considered necessary in cases of:

  1. clarification of unexpected biochemical test results (e.g. high homocysteine, fibrinogen, D-dimer)
  2. in cases of high-risk pregnancy (older age), infertility, or regular miscarriages
  3. in unspecified personal or family history of cardiovascular diseases - thromboembolism

We recommend the CVD 20 research gene analysis package. For more information about genetic thrombophilia read the related page



A simple blood test is required for laboratory testing.

No preparation or diet is required. Blood sampling can be done at any time of the day.


Blood sampling can be done at any time of the day (the laboratory's working hours are 7.30 am – 7.30 pm).


The results are given on the same day for the biochemical testing analyses, between 3 days for the immunological testing analyses, and between 15 days for the gene testing.


According to our latest update, laboratory biochemical and immunological control tests (except αCL IgA ) are prescribed at EOPYY, with the participation of the examinee as the referral defines (15%, unless otherwise stated).

In gene analyses, only the MTHFR gene is prescribed through the EOPYY.

The cost with private coverage of analyzes is structured according to the level of laboratory testing. For reference, this is:

Level A check up: 77 euros (-25% package discount, excluding fibrinogen and homocysteine) = 64 euros

Level B check: 134 euros (-25% package discount) = 100.50 euros

Genetic testing of 20 genes 180 euros. For more information about genetic thrombophilia read the related page

Information selected - indicative with sources: Interpretation of Diagnostic Tests - J.Wallach and

The choice and explanation of the use of the analysis is the exclusive responsibility of your doctor

Edited by : Ioannis Grattisia Head of Laboratory / MSc Clinical Biochemistry - Molecular Biology

2022 - 2023

Biopathology Diagnostic Laboratory | Microbiological | Molecular | DNA | Ultrasonic | EOPYY – Clinic

Diagnostic: Director Biochemist I. Gratsia - Biopathologist I. Katsavochristos / M. Kolokouri - Radiologist S. Alagiannis

Doctors: General Practitioner X. Chrysanthaki - Endocrinologist E. Typhoxylou – Cardiologist A. Castanas - Neurologist C. Karagiorgis - Urologist K. Psyllias - Pulmonologist Zafiria Barbaressou

Liability & Responsibility Ethics in Biomedical Science - Personalised Medical Practice with Courtesy and Empathy

Top 5-star examinee satisfaction performance in users via Google / Doctor any Time

Quality in diagnostic tests

Personal Data Security GDPR

e - Dating via Doctor Anytime at: Cardiologist - Urologist - Neurologist -Diagnostic Examinations

News Blogs: - -

Biopathology Diagnostic Center – Athens | Medical Center Check Up Medicus | Checkup – Blood tests – EOPYY.

Contact us

Send us an email or call us in order to plan an appointment with a doctor or a health check-up.

Check Up Medicus | Medical Center Athens | Blood Tests | Covid-19 Test
Compare items
  • Total (0)